Summit Therapeutics, Inc. (SMMT)
Summit Therapeutics Market Cap : 17.12B for April 30, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Revolution Medicines, Inc. | 28.35B |
| BioMarin Pharmaceutical, Inc. | 10.48B |
| Eli Lilly & Co. | 840.92B |
| Merck & Co., Inc. | 271.77B |
| Soleno Therapeutics, Inc. | 2.728B |
Market Cap Related Metrics
| PEG Ratio | -0.0413 |
| Price to Book Value | 25.98 |
| Price | 22.08 |
| Earnings Yield | -6.54% |
| PEGY Ratio | -0.0413 |